HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cystic Fibrosis Foundation Therapeutics Inc.

Division of Cystic Fibrosis Foundation
www.cff.org/research/cfft/

Latest From Cystic Fibrosis Foundation Therapeutics Inc.

Arcturus Founder Reinstated As CEO As Settlement Ends Four-Month Feud With Former Board

The unexpected firing of Arcturus CEO Joseph Payne kicked off a bitter public battle for control of the RNA therapeutics firm after a reverse merger with Alcobra in November. The dispute now settled, the new board has reinstated Payne at Arcturus' helm.

Legal Issues Business Strategies

Corbus Cystic Fibrosis Data May Justify Longer, Larger Study

Safety was the primary endpoint in a Phase II study for the inflammation-targeting drug anabasum, but Corbus believes an efficacy signal viewed outside of the secondary endpoints justifies further development.

Clinical Trials Respiratory

Alcresta Pharmaceuticals Inc.

Alcresta Pharmaceuticals Inc. aims to combat malabsorption, with an initial focus on enzyme deficiencies, for people with gastrointestinal disorders and rare diseases. It is developing a pipeline of point-of-care nutritional products tailored to maximize the absorption of calories or specific nutrients, based on cartridges enclosing enzymes immobilized onto polymer beads.

BioPharmaceutical Consumer

Alcresta Pharmaceuticals Inc.

Alcresta Pharmaceuticals Inc. aims to combat malabsorption, with an initial focus on enzyme deficiencies, for people with gastrointestinal disorders and rare diseases. It is developing a pipeline of point-of-care nutritional products tailored to maximize the absorption of calories or specific nutrients, based on cartridges enclosing enzymes immobilized onto polymer beads.

BioPharmaceutical Consumer
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register